Home Разное Latest News and Articles Beyond Mood Stabilizers: Optimizing Bipolar Disorder Treatment with Adjunctive Therapies

Beyond Mood Stabilizers: Optimizing Bipolar Disorder Treatment with Adjunctive Therapies

0
Beyond Mood Stabilizers: Optimizing Bipolar Disorder Treatment with Adjunctive Therapies

For individuals living with bipolar disorder, achieving stable mood regulation often requires more than just a standard mood stabilizer like lithium or valproate. While these medications remain foundational, many patients experience breakthrough symptoms – agitation, fatigue, impulsivity, or shifts in mood – that necessitate additional treatment approaches. Psychiatrists increasingly recognize the need for “adjunctive” therapies to bridge the gap between baseline stability and full functional recovery.

Why Add-Ons Matter: When symptoms persist despite primary medication, it signals that monotherapy isn’t enough. Breakthrough episodes mirror relapse symptoms, including sleep disturbances, extreme mood changes, appetite fluctuations, and racing thoughts. Rather than tolerate ongoing instability, doctors often turn to add-on medications to reduce frequency and severity of these events. The choice depends on the predominant symptoms a patient experiences.

Here are seven options currently considered, with practical details to understand their use:

1. Lamotrigine (Lamictal): Targeting Depression in Bipolar Cycles

Originally an anticonvulsant, lamotrigine has proven effective in stabilizing mood and reducing depressive phases in bipolar disorder. However, dosage increases must be slow – no faster than every two weeks – to mitigate the rare but serious risk of Stevens-Johnson syndrome, a severe skin reaction. Despite this risk, lamotrigine remains a valuable option for those with depression-heavy cycles.

2. Cariprazine (Vraylar): Balancing Mania and Depression

Approved by the FDA for both manic/mixed episodes and bipolar depression, cariprazine acts as a dopamine modulator, adjusting neurotransmitter levels as needed. This “top-down” approach is useful for patients who experience both extreme highs and lows.

3. Lumateperone (Caplyta): Managing Bipolar Depression with Fewer Side Effects

Lumateperone targets serotonin, dopamine, and glutamate to alleviate depressive symptoms while minimizing weight gain and movement disorders – common issues with older antipsychotics. Its tolerability makes it a preferred choice for some individuals.

4. Aripiprazole (Abilify): Regulating Energy Levels

Initially used for psychosis, aripiprazole can also stabilize mood in bipolar disorder, leading to more consistent energy levels. However, it carries potential side effects like weight gain, metabolic changes (increasing diabetes risk), and akathisia – a distressing restlessness.

5. Quetiapine (Seroquel): Comprehensive Mood Coverage

Quetiapine is highly sedating at lower doses, aiding with insomnia often seen in bipolar disorder. Higher doses provide robust anti-manic and anti-depressive effects. Careful monitoring of weight, blood glucose, and lipid levels is essential due to the risk of metabolic syndrome.

6. Lurasidone (Latuda): Addressing Stubborn Depression

Lurasidone targets dopamine and serotonin to improve mood regulation, particularly in bipolar depression. A critical requirement: it must be taken with a meal of at least 350 calories to ensure proper absorption and efficacy.

7. Ketamine (Emerging NMDA Modulators): Rapid, Temporary Relief

Though not FDA-approved for bipolar disorder, ketamine and similar NMDA modulators are being studied for rapid antidepressant effects. These agents target glutamate rather than serotonin or dopamine, offering immediate relief in acute cases, such as suicidal ideation. However, their long-term safety and efficacy are still under investigation.

A Practical Approach: If you’re stable but not well, or if side effects from your primary medication become intolerable, it’s time to discuss adjunctive therapy with your doctor.

Key Questions to Ask Your Doctor:

  • Which add-on is best for my specific symptoms?
  • What’s the expected timeline for improvement?
  • What are the most common and serious side effects?
  • How will this interact with my current medications?
  • What monitoring is required (weight, blood sugar, etc.)?

Conclusion: While mood stabilizers are essential, many individuals with bipolar disorder require additional medications to achieve true symptom control. Adjunctive treatments address breakthrough symptoms when they emerge, and open discussions with your healthcare provider can lead to more effective and personalized care.

Exit mobile version